Embryo cryostorage duration and fetal growth outcomes after single-blastocyst frozen embryo transfer: a retrospective cohort study
- 1Department of Reproductive Medicine, The Reproductive Hospital of Guangxi Zhuang Autonomous Region
- 2Network and Information Center, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region
Abstract
Background: With increasing demand for fertility preservation and delayed childbearing, long-term embryo cryostorage has become increasingly common. The potential effects of embryo cryostorage duration on offspring health have attracted considerable attention. However, evidence regarding its association with fetal growth outcomes among offspring conceived after single-blastocyst frozen embryo transfer (FET) remains limited.
Materials and methods: This retrospective cohort study included 4,974 women who achieved singleton live births after the transfer of a single vitrified-warmed blastocyst at the Reproductive Hospital of Guangxi Zhuang Autonomous Region between January 2013 and June 2024. Participants were categorized into five groups according to embryo cryostorage duration: 0–3 months, 3–6 months, 6–12 months, 1–3 years, and >3 years. Multivariable logistic regression was used to examine the associations between cryostorage duration and perinatal outcomes, and restricted cubic spline (RCS) models were applied to assess continuous and potential nonlinear associations. Propensity score matching and E-value analyses were further conducted to evaluate the robustness of the findings.
Results: Compared with embryos stored for 0–3 months, embryos stored for >3 years were associated with higher odds of LGA (aOR, 1.78; 95% CI, 1.31–2.43) and lower odds of SGA (aOR, 0.55; 95% CI, 0.35–0.88), whereas no statistically significant association with macrosomia was observed after full adjustment. RCS analyses showed statistically significant overall associations with SGA (P = 0.029) and LGA (P = 0.021), with evidence of nonlinearity for LGA (P = 0.049) but not SGA (P = 0.449). Sensitivity analyses yielded broadly consistent results for LGA.
Conclusion: Among singleton live births following single-blastocyst FET, longer embryo cryostorage duration was associated with higher odds of LGA, whereas lower odds of SGA were observed across categorical and RCS analyses. These findings warrant confirmation in studies with more detailed treatment-cycle and maternal clinical data.
Related
- Trigger-day progesterone-to-mature-oocyte ratio, cycle-level blastocyst yield, and recorded embryo-transfer outcomes: a retrospective cohort study
- The effect of embryo vitrification duration on frozen-thawed transfer outcomes: the key moderating role of age—a retrospective cohort study of 13,054 cycles
- Sequential blastocyst transfer improved pregnancy outcomes in patients undergoing frozen-thawed embryo transfer cycles: who will be the ultimate beneficiary
- Effect of the 'Ready-to-Use Vitrification and Warming Kit' on Pregnancy Rates Following Vitrification-warmed Blastocyst Transfer: A Retrospective Study.
- Genetic and non-genetic contributions to early spontaneous miscarriage in women with PCOS undergoing PGT-A and single euploid blastocyst transfer: a retrospective cohort study
BibTeX
@article{wan2026embryo,
title = {{Embryo cryostorage duration and fetal growth outcomes after single-blastocyst frozen embryo transfer: a retrospective cohort study}},
author = {Jiangfan Wan and Kali Huang and Anran Wang and Bowen Wei and Shanjia Yi and Weiwei Luo and Li Deng and Pei Yuan},
journal = {Frontiers in Endocrinology},
year = {2026},
month = nov,
doi = {10.3389/fendo.2026.1925376},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1925376/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Embryo cryostorage duration and fetal growth outcomes after single-blastocyst frozen embryo transfer: a retrospective cohort study
AU - Jiangfan Wan
AU - Kali Huang
AU - Anran Wang
AU - Bowen Wei
AU - Shanjia Yi
AU - Weiwei Luo
AU - Li Deng
AU - Pei Yuan
PY - 2026
DA - 2026/11/16
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1925376
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1925376/full
AB - Background: With increasing demand for fertility preservation and delayed childbearing, long-term embryo cryostorage has become increasingly common. The potential effects of embryo cryostorage duration on offspring health have attracted considerable attention. However, evidence regarding its association with fetal growth outcomes among offspring conceived after single-blastocyst frozen embryo transfer (FET) remains limited. Materials and methods: This retrospective cohort study included 4,974 women who achieved singleton live births after the transfer of a single vitrified-warmed blastocyst at the Reproductive Hospital of Guangxi Zhuang Autonomous Region between January 2013 and June 2024. Participants were categorized into five groups according to embryo cryostorage duration: 0–3 months, 3–6 months, 6–12 months, 1–3 years, and >3 years. Multivariable logistic regression was used to examine the associations between cryostorage duration and perinatal outcomes, and restricted cubic spline (RCS) models were applied to assess continuous and potential nonlinear associations. Propensity score matching and E-value analyses were further conducted to evaluate the robustness of the findings. Results: Compared with embryos stored for 0–3 months, embryos stored for >3 years were associated with higher odds of LGA (aOR, 1.78; 95% CI, 1.31–2.43) and lower odds of SGA (aOR, 0.55; 95% CI, 0.35–0.88), whereas no statistically significant association with macrosomia was observed after full adjustment. RCS analyses showed statistically significant overall associations with SGA (P = 0.029) and LGA (P = 0.021), with evidence of nonlinearity for LGA (P = 0.049) but not SGA (P = 0.449). Sensitivity analyses yielded broadly consistent results for LGA. Conclusion: Among singleton live births following single-blastocyst FET, longer embryo cryostorage duration was associated with higher odds of LGA, whereas lower odds of SGA were observed across categorical and RCS analyses. These findings warrant confirmation in studies with more detailed treatment-cycle and maternal clinical data.
SN - 1664-2392
ER -